Hepatobiliary Neoplasia 1: Clinical Behaviors
Nov
2026
Description
This session presents advances in HCC detection and prognostication, including deep learning imaging models, circulating biomarkers, and structured surveillance program outcomes.
Presentations
11:00 AM
- 11:15 AM
Convention Center - Bluebird Ballroom 2ABC
Changing Clinical Patterns and Outcomes of Hepatocellular Carcinoma Across Treatment Eras: A Multicenter Cohort Study
Karim Seif El Dahan, MD | Abstract Presenter
11:15 AM
- 11:30 AM
Convention Center - Bluebird Ballroom 2ABC
Effectiveness of a Structured Surveillance Program for Early Detection of Hepatocellular Carcinoma in Contemporary Patients with Advanced Chronic Liver Disease
Georg GK Kramer, MD | Abstract Presenter
11:30 AM
- 11:45 AM
Convention Center - Bluebird Ballroom 2ABC
A Plasma DNA Methylation Biomarker Panel from the Whole-Body Atlas™ Enables Accurate Detection of Early-Stage HCC
Amit G Singal, MD, MS, FAASLD | Abstract Presenter
11:45 AM
- 12:00 PM
Convention Center - Bluebird Ballroom 2ABC
Circulating Tumor DNA For Early Recurrence Detection and Molecular Residual Disease Monitoring in Hepatocellular Carcinoma and Biliary Tract Cancer: A Real-World Multicenter Analysis
Maen Abdelrahim, MD, PhD, Pharm. D | Abstract Presenter
12:00 PM
- 12:15 PM
Convention Center - Bluebird Ballroom 2ABC
Prediagnostic Circulating Bile Acid Profiles and Liver Cancer Risk Across the Chronic Liver Disease Spectrum
Longgang Zhao, PhD | Abstract Presenter
12:15 PM
- 12:30 PM
Convention Center - Bluebird Ballroom 2ABC
Multimodal image-based deep learning for preoperative prediction of microvascular invasion in hepatocellular carcinoma
Rex Wan-Hin Hui, MBBS, PhD | Abstract Presenter
